First-in-Human Phase I Trial of Two Schedules of OSI-930, a...

Clinical Cancer Research 2013 / 02 Vol. 19; Iss. 4

First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Yap, T. A., Arkenau, H.-T., Camidge, D. R., George, S., Serkova, N. J., Gwyther, S. J., Spratlin, J. L., Lal, R., Spicer, J., Desouza, N. M., Leach, M. O., Chick, J., Poondru, S., Boinpally, R., Gedri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-12-2258
Date:
February, 2013
File:
PDF, 695 KB
english, 2013
Conversion to is in progress
Conversion to is failed